Statin and Wnt inhibitor combination therapy shows reduction in tumor weight and cancer stem cell populations for both epithelial and mesenchymal phenotypes. No concrete conclusions can be drawn from decreased DKK-1 levels. This evidence concerns the gene EEF1A2 and cancer.